<DOC>
	<DOCNO>NCT01316081</DOCNO>
	<brief_summary>In obese child , low antioxidant vitamin intake reduce antioxidant capacity common . Weight reduction reduces subclinical inflammation obese subject , , similarly , antioxidant vitamin show reduce expression proinflammatory cytokine . Moreover , antioxidant reduce oxidative stress influence endothelial function might play crucial role pathogenesis obesity-related disorder . Furthermore , overweight child adult markedly increase risk iron deficiency . The mechanism link obesity iron deficiency unclear . Growing evidence suggest elevate inflammatory status associate obesity increase circulate hepcidin contributes iron deficiency . Weight reduction show associate reduced inflammation serum hepcidin concentration , improve functional iron state . Thus , reduce inflammation obese child may improve iron metabolism reduce risk iron deficiency . Therefore , positive effect subclinical inflammation , hepcidin/iron status metabolic risk factor obese child weight loss may enhance supplementation antioxidant . The aim present study investigate effect 4-month antioxidant supplementation subclinical inflammation , hepcidin , iron status component metabolic syndrome overweight child undergoing outpatient weight-loss program . Our hypothesis : 1 . During outpatient weight loss program , antioxidant supplementation reduce oxidative inflammatory stress associate obesity great extent weight loss alone . 2 . This two effect , compare weight loss alone : a.It reduce circulate hepcidin concentration , improve iron status . b.It improve metabolic cardiovascular risk factor . Subjects The investigator plan enroll 50 child participant outpatient weight-loss program German part Switzerland . Enrollment do agreement assistance physician supervise weight-loss program , time study measurement incorporate within exist program schedule . It anticipate baseline blood sample study obtain regular baseline venipuncture weight-loss study . Criteria participation include age 10 18 year BMI 85th percentile age sex . Exclusion criterion include major medical illness , include gastrointestinal , inflammatory , bleed and/or endocrine disorder , history nephrolithiasis , unusual dietary habit ( e.g . vegetarianism ) , major food allergy intolerance ( lactose , gluten ) , smoke , use chronic medication vitamin/mineral antioxidant supplement . Study design The study double-blind , randomize , placebo-controlled intervention trial . Children randomly assign one two group : antioxidant ( AO ) placebo ( P ) supplement . If necessary enroll child different weight-loss program , randomization stratify program . During 4-month weight loss period , AO group consume oral supplement ascorbic acid ( 500mg ) , alpha tocopherol ( 400 IU ) , 50 Âµg selenium ( Burgerstein Vitamins , Rapperswil-Jona , Switzerland ) evening diner , whereas P group consume identical-appearing placebo supplement .</brief_summary>
	<brief_title>A 4-month Intervention Antioxidant Supplementation Overweight Children</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>age 10 18 year old BMI 85th percentile age sex history nephrolithiasis history bleed disorder smoking type 2 diabetes NAFLD Asthma</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>antioxidant supplementation</keyword>
	<keyword>childhood obesity</keyword>
	<keyword>hepcidin</keyword>
	<keyword>iron status</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>inflammation</keyword>
</DOC>